During the SARS-CoV-2 outbreak, laboratories worldwide have pivoted from their usual research to working to identify new COVID-19 drug and vaccine candidates. This experimental work requires access to clinical isolates and systems that allow genetic manipulation of SARS-CoV-2. A new paper reports an openly available SARS-CoV-2 laboratory research toolkit aimed at increasing availability of these materials.